Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Immediate Postpartum Contraceptive Implants

Am J Obstet Gynecol; ePub 2017 Mar 22; Eggebroten, et al

More than 80% of women initiating an intrauterine device (IUD) or contraceptive implant prior to hospital discharge continued use at 6 months postpartum, a recent study found. This analysis examined in-hospital provision, expulsion, and 6-month continuation of immediate postpartum copper T380 IUDs (Cu IUD), levonorgestrel (LNG) IUDs, and contraceptive implants from October 2013 to February 2016 among 638 patients who requested a postpartum IUD or implant, and 350 patients enrolled in prospective follow-up prior to hospital discharge. Researchers found:

  • 325 (93%) women received their preferred contraceptive device prior to hospital discharge: 27% Cu IUD users, 38% LNG IUD users, and 35% implant users.
  • At 6 months postpartum, 289/325 (89%) device recipients completed follow-up.
  • There was no statistically significant difference in expulsions by delivery type or continuation by device type.
  • 6-month device continuation was ≥80% for all device types.


Eggebroten JL, Sanders JN, Turok DK. Immediate postpartum intrauterine device and implant program outcomes: A prospective analysis. [Published online ahead of print March 22, 2017]. Am J Obstet Gynecol. doi:10.1016/j.ajog.2017.03.015.